Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Klin Med (Mosk) ; 94(2): 138-43, 2016.
Article Ru | MEDLINE | ID: mdl-27459764

AIM: To study the neuroprotective effect of a repeated course of low dose cortexin therapy on the quality of life in the early rehabilitative period after hemispheric ischemic stroke (IS). MATERIALS AND METHODS: 90 patients were divided into group 1 treated with cortexin (10 mg i/m twice daily (morning and afternoon) in addition to basal treatment, group 2 given the repeated course of the same treatment, and control group (basal therapy alone). The standard SF-36 questionnaire was used to assess the quality of life. RESULTS: Treatment of patients following acute hemispheric ischemic stroke with cortexin (10 mg i/m twice daily) and the repeated course of the same treatment after 10 days resulted in the accelerated and more complete normalization of the quality of life in the early rehabilitation petriod (starting from days 21-27 days after the onset of disease) than in the patients given a single course of cortexin therapy or basal treatment alone.


Brain Ischemia/drug therapy , Neuroprotective Agents/pharmacology , Outcome Assessment, Health Care , Peptides/pharmacology , Quality of Life , Stroke/drug therapy , Aged , Aged, 80 and over , Humans , Intercellular Signaling Peptides and Proteins , Middle Aged , Neuroprotective Agents/administration & dosage , Peptides/administration & dosage
...